In conclusion, the present study shows that combination of EGFR kinase inhibitors with ionizing radiation could be a potent therapeutic strategy to treat anaplastic oligodendrogliomas characterized by EGFR abnormalities. The gene discussed is EGFR; the disease is anaplastic oligodendroglioma.